12–1pm 20 October 2017
Associate Professor Enzo R Porrello, Murdoch Childrens Research Institute, The Royal Children’s Hospital, Parkville, VIC, Department of Physiology, The University of Melbourne, Parkville, VIC and School of Biomedical...
12–1pm 18 October 2017
Dr Rachel Li, The Parish Group - Cancer & Vascular Biology, JCSMR
Total joint replacement: New biomaterial and osteoimmunology research for better outcomes.
Dr Dan Andrews, The Andrews Group, JCSMR
3.30–4.30pm 13 October 2017
Dr Nathalie Dehorter, The Dehorter Group, Eccles Institute of Neuroscience, JCSMR, ANU
12–1pm 13 October 2017
Associate Professor Chen Davidovich, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, VIC, 3800, and EMBL-Australia and the ARC Centre of Excellence in Advanced Molecular...
12–1pm 11 October 2017
Ms Sarita Dhounchak, The Simeonovic Group, JCSMR
Final PhD presentation.
3.30–4.30pm 6 October 2017
Deborah Feakes, The Stricker Group, JCSMR, ANU
12–1pm 6 October 2017
Dr Justin Boddey, NHMRC CDF2 Fellow, Laboratory Head, Infection and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC
Malaria parasites injected into the skin by a mosquito rapidly infect...
3.30–4.30pm 22 September 2017
Emeritus Professor Angela Dulhunty, Dulhunty Group - Muscle Research, The Eccles Institute of Neuroscience, JCSMR, ANU
12–1pm 22 September 2017
Professor David Vaux, Deputy Director and Joint Division Head, Cell Signalling and Cell Death, WEHI
Science is knowledge gained through repeated observation or experiment. It is communicated through publication of papers in...
12.30–1.30pm 21 September 2017
Dr Doris Beylkin, GE Dharmacon, Colorado, USA
RNAi has long been used for functional genomics screening in cell-based assays. CRISPR is newer to this application, but showing promise as a complimentary, and possibly more...
3.30–4.30pm 15 September 2017
Dr Saba Gharaei, The Stuart Group - Neuronal Signalling, JCSMR
3.30–4.30pm 14 September 2017
Konstantin Panov, PhD, Queen`s University, Belfast
12–1pm 13 September 2017
Making sense of a novel RC3H1 nonsense mutation associated with Hemopagocytic Lymphohistocytosis (HLH)
Dr Vicki Athanasopoulos, The Vinuesa Group, JCSMR
The Aryl Hydrocarbon Receptor (AhR)-dependant cytotoxic...
3.30–4.30pm 8 September 2017
Emeritus Professor Trevor Lamb, The Lamb Group - Visual Neuroscience, The Eccles Institute for Neurocience, JCSMR, ANU
3.30–4.30pm 8 September 2017
Barbara Holland, University of Tasmania
Joint work with: Jeremy Sumner, David Liberles, Michael Woodhams, Michael Charleston
These days the most widely used methods of phylogenetic inference are based...
12–1pm 6 September 2017
Mr Hao Yang, The McMorran Group JCSMR.
Final PhD Seminar -
12–1pm 1 September 2017
CANCELLED DUE TO FLIGHT DELAYS - WILL BE RESCHEDULED
Professor Trevor Kilpatrick, Director, Melbourne Neuroscience Institute, University of Melbourne, Melbourne, VIC
Multiple sclerosis (MS) is traditionally considered a T...
3.30–4.30pm 31 August 2017
Dr Denis Bauer, CSIRO
The genome holds information on prospective disease risk. Hence by 2025, 50% of the world population will have their genome sequenced. This will create more data than Astronomy, Twitter, and YouTube...
5.30–6.15pm 28 August 2017
The World Health Organization estimated that the number of people with diabetes globally was 442 million in 2014. In Australia, it is the most common cause of renal failure, of blindness in working age adults, and of non-...
12–1pm 25 August 2017
Please note - this seminar has been been cancelled due to illness and will be rescheduled.
Brandon Wainwright is Professor and Director of the Institute for Molecular Bioscience (IMB) at the University of Queensland. The...